---
title: "Maccura: The company has not yet engaged in the layout of stem cell therapy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/244991437.md"
description: "On June 18th, Maccura stated on the interactive platform that the company focuses on independent research and development, production, and sales of in vitro diagnostic products and services, and has not yet involved itself in the layout of stem cell therapy"
datetime: "2025-06-18T01:10:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/244991437.md)
  - [en](https://longbridge.com/en/news/244991437.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/244991437.md)
generator: "portal-rs"
---

# Maccura: The company has not yet engaged in the layout of stem cell therapy

On June 18th, Maccura stated on the interactive platform that the company focuses on the independent research and development, production, and sales of in vitro diagnostic products and services, and has not yet involved itself in the layout of stem cell therapy

### Related Stocks

- [300463.CN](https://longbridge.com/en/quote/300463.CN.md)

## Related News & Research

- [dormakaba calls shareholder meeting to vote on ownership structure simplification](https://longbridge.com/en/news/297595532.md)
- [Cofoe Medical FY26 H1 profit climbs 21.9% to RMB 203.2 million; revenue rises 38.5% to RMB 2.07 billion](https://longbridge.com/en/news/297291709.md)
- [Independent Oil & Resources H1 net profit rises 0.74% to NOK 25.8 million](https://longbridge.com/en/news/297475302.md)
- [CRNA: NOK 620 million raised, circVec platform validated, and financial position transformed](https://longbridge.com/en/news/297550117.md)
- [Shyft Partners With VARA-Licensed GAP3 as shCORE and shYIELD Near Pre-Deposits](https://longbridge.com/en/news/297355503.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**